XERS Xeris Biopharma Holdings, Inc.

$6.95 +0.72%

Healthcare · Pharmaceutical Preparations

Xeris Biopharma Holdings, Inc. (XERS) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $1.2 billion. Shares last traded at $6.95, 31.0% below their 52-week high. Over the past year the stock is up 53.4%. XERS trades at a price-to-earnings ratio of 2165.82, above the Pharmaceutical Preparations median of 16.82. Net profit margin is 0.2%, above the peer median of -0.1%. Revenue grew 43.7% year over year.

Market Cap

$1.2B

Shares Out

172.6M

EPS (TTM)

$-0.19

P/E Ratio

2165.82

P/S Ratio

4.11

P/B Ratio

92.22

Dividend / Share

—

Dividend Yield

—

52-Week High

$10.07

52-Week Low

$4.42

Volume

123,882

Avg Vol (3m)

92,360.937

Performance

+0.29%

+17.40%

+24.44%

-2.11%

YTD

-5.44%

+53.42%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

65.69

SMA (50)

$6.27

SMA (200)

$7.04

Price vs SMA50

+10.79%

Price vs SMA200

-1.30%

ATR (14)

$0.41

Financials

Revenue

$292M

Net Income

$1M

Gross Margin

—

Operating Margin

8.5%

Net Margin

0.2%

Return on Equity

4.3%

Return on Assets

0.1%

Current Ratio

2.12

Debt / Equity

17.00

Revenue Growth (YoY)

+43.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.01	2026-05-07
FY 2025	$0.00	2026-03-02
Q3 2025	$-0.07	2025-11-06
Q2 2025	$-0.07	2025-08-07
Q1 2026	$-0.06	2026-05-07
FY 2025	$-0.37	2026-03-02

Full earnings history →

Pharmaceutical Preparations peers

XERS vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

2165.82 / 16.82 med

+12780% premium

P/S vs peers

4.11 / 3.54 med

+16% premium

Net margin vs peers

0.2% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.